                               SEQUENCE LISTING

<110> EIRION THERAPEUTICS, INC.
 
<120> DELAYING PEAK EFFECT AND/OR EXTENDING DURATION OF RESPONSE

<130> 2012317-0236

<140> PCT/US2020/032458
<141> 2020-05-12

<150> 62/847,901
<151> 2019-05-14

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 1
Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


Lys Lys Lys Lys Lys Lys Lys Lys Lys Gly Arg Lys Lys Arg Arg Gln 
            20                  25                  30          


Arg Arg Arg 
        35  


